SpectRx, Inc. Signs Agreement to Manufacture and Supply New Non-invasive Cancer Detection Devices

NORCROSS, Ga.--(BUSINESS WIRE)--SpectRx, Inc. (Pink Sheets: SPRX), today announced it has entered into a manufacturing agreement with the MacKay Group, Ltd. to supply non-invasive breast and cervical cancer detection products for certain territories within the Asian market. Under terms of the agreement, SpectRx plans to contract manufacture for MacKay 1,000 Biofield Breast Diagnostic Systems, and MacKay plans to purchase a specified minimum number of SpectRx’s LightTouch™ Non-invasive Cervical Cancer Detection Devices and associated single-patient-use disposables.